HUP9701437A2 - Komplex lipidek felhasználása stabilizáló adalékként emésztőenzim-keverékeket tartalmazó gyógyászati készítményekben, gyógyászati készítmények és kitek - Google Patents

Komplex lipidek felhasználása stabilizáló adalékként emésztőenzim-keverékeket tartalmazó gyógyászati készítményekben, gyógyászati készítmények és kitek

Info

Publication number
HUP9701437A2
HUP9701437A2 HU9701437A HUP9701437A HUP9701437A2 HU P9701437 A2 HUP9701437 A2 HU P9701437A2 HU 9701437 A HU9701437 A HU 9701437A HU P9701437 A HUP9701437 A HU P9701437A HU P9701437 A2 HUP9701437 A2 HU P9701437A2
Authority
HU
Hungary
Prior art keywords
kits
pharmaceutical
complex
lipides
compositions containing
Prior art date
Application number
HU9701437A
Other languages
English (en)
Inventor
Manfred Galle
Original Assignee
Solvay Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals Gmbh filed Critical Solvay Pharmaceuticals Gmbh
Publication of HU9701437D0 publication Critical patent/HU9701437D0/hu
Publication of HUP9701437A2 publication Critical patent/HUP9701437A2/hu
Publication of HUP9701437A3 publication Critical patent/HUP9701437A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

A találmány tárgya kőmplex lipidek - különösen lecitin - felhasználásanedvesség hatására bekövetkező lipőlitikűs aktivitáscsökkenéstmegakadályőzó stabilizáló adalékként lipázőkat és prőteázőkattartalmazó emésztőenzim-keverékeket - különösen pankkreatintartalmúemésztőenzim-keverékeket - magűkban főglaló, a győmőrbélrendszerbeszőnda segítségével főlymatősan bevezethető vizes őldatőkelőállítására alkalmas vízőldható gyógyászati készítményekben. Atalálmány tárgya képezik tővábbá gyógyászati készítmények és kitek. ŕ
HU9701437A 1996-08-28 1997-08-25 Use of complex lipides as stabilizing additives in pharmaceutical compositions containing digestive enzymes, pharmaceutical compns. and kits HUP9701437A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19634752 1996-08-28
DE19724845A DE19724845A1 (de) 1996-08-28 1997-06-12 Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen

Publications (3)

Publication Number Publication Date
HU9701437D0 HU9701437D0 (en) 1997-10-28
HUP9701437A2 true HUP9701437A2 (hu) 1998-03-30
HUP9701437A3 HUP9701437A3 (en) 2001-03-28

Family

ID=26028823

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9701437A HUP9701437A3 (en) 1996-08-28 1997-08-25 Use of complex lipides as stabilizing additives in pharmaceutical compositions containing digestive enzymes, pharmaceutical compns. and kits

Country Status (22)

Country Link
US (1) US5993806A (hu)
EP (1) EP0826375B1 (hu)
JP (1) JP4593697B2 (hu)
CN (1) CN1199694C (hu)
AR (1) AR008807A1 (hu)
AT (1) ATE284225T1 (hu)
AU (1) AU722151B2 (hu)
BR (1) BR9704554B1 (hu)
CA (1) CA2213151C (hu)
CZ (1) CZ295329B6 (hu)
DE (2) DE19724845A1 (hu)
DK (1) DK0826375T3 (hu)
EE (1) EE04179B1 (hu)
ES (1) ES2235206T3 (hu)
HK (1) HK1005224A1 (hu)
HU (1) HUP9701437A3 (hu)
NO (1) NO973940L (hu)
NZ (1) NZ328616A (hu)
PL (1) PL190140B1 (hu)
PT (1) PT826375E (hu)
SK (1) SK284639B6 (hu)
TR (1) TR199700872A3 (hu)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6074689A (en) * 1998-03-10 2000-06-13 Immucell Corporation Colonic delivery of protein or peptide compositions
KR100367659B1 (ko) * 2000-05-08 2003-01-14 주식회사 바이넥스 선택적 안정화제의 첨가에 따른 자가분해(autolysis)를 통한 고역가 판크레아틴의 제조방법
GB0019118D0 (en) * 2000-08-03 2000-09-27 Danisco Solid phase glycerolysis
ATE295737T1 (de) * 2000-11-02 2005-06-15 Cilian Ag Verwendung von aus ciliaten gewonnenen enzymen als verdauungsfördernde arzneimittel
US20030099626A1 (en) * 2001-11-20 2003-05-29 Health Education Corporation Nutrient absorption enhancing compositions and methods
BRPI0509148B8 (pt) * 2004-03-22 2021-05-25 Abbott Products Gmbh composições farmacêuticas orais de produtos contendo lipase, em particular de pancreatina contendo tensoativos, seus usos e respectivos processos de fabricação
US7153504B2 (en) * 2004-07-30 2006-12-26 Can Technologies, Inc. Stabilized pancreas product
WO2007012069A2 (en) * 2005-07-20 2007-01-25 Brophy James S Modification of particle morphology to improve product functionality
JP5140586B2 (ja) 2005-07-29 2013-02-06 アボット プロダクツ ゲゼルシャフト ミット ベシュレンクテル ハフツング 滅菌パンクレアチン粉末の製法
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20110183050A1 (en) * 2006-07-20 2011-07-28 Brophy James S Modification of particle morphology to improve product functionality
US8444967B2 (en) 2010-07-09 2013-05-21 Master Supplements, Inc. Treatment including prebiotic composition for use with probiotics
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
DE102009006594A1 (de) 2009-01-29 2010-08-05 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutisches Präparat
CN102231988A (zh) * 2009-01-29 2011-11-02 诺尔玛克药物有限责任及股份两合公司 细菌脂肪酶药物制剂
MX348118B (es) 2010-10-01 2017-05-26 Aptalis Pharma Ltd Formulaciones de pancrelipasa con recubrimiento enterico de baja potencia.
EP3030257B1 (en) 2013-08-09 2020-02-19 Allergan Pharmaceuticals International Limited Digestive enzyme composition suitable for enteral administration
EP3003360B1 (en) * 2013-11-05 2020-10-07 Allergan Pharmaceuticals International Limited High potency pancreatin pharmaceutical compositions
JP2014193909A (ja) * 2014-06-04 2014-10-09 Nordmark Arzneimittel Gmbh & Co Kg 医薬調製物
TR201704471T1 (tr) * 2014-11-05 2018-04-24 Abbott Gmbh & Co Kg Pankreatin İhtiva Eden İyileştirilmiş Güvenlik Profiline Sahip Bileşimlerin Üretilmesi İçin Prosesler Ve Farmasötik Kullanıma Uygun Bileşimler
US20180028454A1 (en) 2015-02-04 2018-02-01 Abbvie Inc. Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency
DE102015114862A1 (de) * 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutische Zusammensetzung, enthaltend eine bakterielle Lipase
DE102015114857A1 (de) 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Getränk, enthaltend eine pharmazeutische Zusammensetzung

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956483A (en) * 1968-10-24 1976-05-11 Wilson Pharmaceutical & Chemical Corporation Preparing pancreatin
US3991180A (en) * 1972-03-06 1976-11-09 Rohm And Haas Company Stabilization of internally administered pancreatic lipase
DE2512746C3 (de) * 1975-03-22 1980-04-24 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von keimarmem, faserfreiem Pankreatin
GB1603640A (en) * 1977-07-20 1981-11-25 Gist Brocades Nv Enzyme particles
JPS58148814A (ja) * 1982-03-01 1983-09-05 Fujimoto Seiyaku Kk 消化酵素軟カプセル剤
JPS59169491A (ja) * 1983-03-15 1984-09-25 Duskin Franchise Co Ltd 酵素の安定化法
JPH0229950A (ja) * 1988-07-18 1990-01-31 Nec Corp 光ディスク
JP2679852B2 (ja) * 1989-11-29 1997-11-19 株式会社サム研究所 経口及び局所投与用生物活性蛋白組成物
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
ZA92452B (en) * 1991-01-24 1992-10-28 Martek Corp Microbial oil mixtures and uses thereof
DE4200002A1 (de) * 1992-01-02 1993-07-08 Rudolf V Dipl Chem Dr Noronha Reinigungstablette fuer die zahnprothesen
CA2168870A1 (en) * 1993-09-15 1995-03-23 Anthony Vincent Rawlings Skin care method and composition
JPH09125096A (ja) * 1995-10-30 1997-05-13 Koei Sangyo:Kk 液状天然油脂洗剤

Also Published As

Publication number Publication date
US5993806A (en) 1999-11-30
SK115997A3 (en) 1998-07-08
BR9704554B1 (pt) 2011-12-27
BR9704554A (pt) 1998-09-15
NO973940L (no) 1998-03-02
AU722151B2 (en) 2000-07-20
CA2213151A1 (en) 1998-02-28
JPH1077236A (ja) 1998-03-24
EP0826375A2 (de) 1998-03-04
AR008807A1 (es) 2000-02-23
PL190140B1 (pl) 2005-11-30
PT826375E (pt) 2005-02-28
EE04179B1 (et) 2003-12-15
NZ328616A (en) 1999-01-28
AU3530997A (en) 1998-03-05
TR199700872A2 (xx) 1999-04-21
SK284639B6 (sk) 2005-08-04
CZ218497A3 (cs) 1998-03-18
CZ295329B6 (cs) 2005-07-13
HK1005224A1 (en) 1998-12-31
CN1199694C (zh) 2005-05-04
EP0826375A3 (de) 2002-08-14
DK0826375T3 (da) 2005-01-24
ATE284225T1 (de) 2004-12-15
TR199700872A3 (tr) 1999-04-21
EE9700249A (et) 1998-04-15
EP0826375B1 (de) 2004-12-08
ES2235206T3 (es) 2005-07-01
CN1174743A (zh) 1998-03-04
PL321825A1 (en) 1998-03-02
NO973940D0 (no) 1997-08-27
DE19724845A1 (de) 1998-03-05
JP4593697B2 (ja) 2010-12-08
CA2213151C (en) 2008-04-01
HUP9701437A3 (en) 2001-03-28
HU9701437D0 (en) 1997-10-28
DE59712108D1 (de) 2005-01-13

Similar Documents

Publication Publication Date Title
HUP9701437A2 (hu) Komplex lipidek felhasználása stabilizáló adalékként emésztőenzim-keverékeket tartalmazó gyógyászati készítményekben, gyógyászati készítmények és kitek
NO20014507D0 (no) Legemiddel for behandling av sukkersyke
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
GB1510925A (en) Chromogenic enzyme substrates
DK0460062T3 (da) Huperzin A-analoger
AU563831B2 (en) N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
IL95391A0 (en) Substituted n-(quinolin-2-yl-methoxy)benzyl-sulphonyl-ureas,their preparation and pharmaceutical compositions containing them
HUP9902081A2 (hu) Gyulladásgátlóként használható, kéntartalmú di(terc-butil)-fenol-vegyületek
Mangla et al. Simultaneous electrophoresis of pepsinogens and pepsins
RU95113437A (ru) (h±)-сложный этиловый эфир транс-2-диметиламино-1-фенил-3-циклогексентранс-1-карбоновой кислоты в виде первичного ортофосфата и твердая фармацевтическая композиция с обезболивающей активностью
DE69713588D1 (de) Diagnostische zusammensetzung
HUP9801439A2 (hu) Béta-D-Galakotpiranozil-D-xilózok alkalmazása bél laktáz kimutatására alkalmas készítmények és oldatok előállításánál, valamint eljárás a vegyületek előállítására
SE8500093D0 (sv) Urokinasderivat urokinasderivat
HUP9903892A2 (hu) Hidroxámsavszármazékok
BG104452A (en) New derivatives of the methylenebisphosphonic acid
ATE4637T1 (de) Pentadecapeptid, verfahren zu seiner herstellung und immunisierendes mittel.
GB1313318A (en) Pharmaceutical preparation for the treatment of hemorrhoids
OA06185A (fr) Nouvelles compositions pharmaceutiques à base d'enzyme bactérien.
HUP9900942A2 (hu) In situ képződő gyógyszerforma enzimek sebekre való juttatására
JPS525786A (en) Preparation of 3-cephem-3,4-dicarboxylic acid derivativese

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees